A Comparative study of Epidemiology, clinical presentation and serology of syphilis in HIV and Non-HIV patients. by Karthikeyan, R
A COMPARATIVE STUDY OF EPIDEMIOLOGY, CLINICAL 
PRESENTATION AND SEROLOGY OF SYPHILIS IN HIV 
AND NON - HIV PATIENTS
Dissertation Submitted  in 
fulfillment of the university regulations for 
 MD DEGREE IN
DERMATOLOGY, VENEREOLOGY AND LEPROSY
(BRANCH XII A)
THE TAMILNADU DR.M.G.R. MEDICAL 
UNIVERSITY
CHENNAI.
SEPTEMBER  2006
CERTIFICATE
Certified   that   this   dissertation   entitled  "A COMPARATIVE STUDY OF 
EPIDEMIOLOGY, CLINICAL PRESENTATION AND SEROLOGY OF SYPHILIS IN 
HIV AND NON - HIV PATIENTS” is a bonafide work done by Dr.R.KARTHIKEYAN, 
Post Graduate Student of Department of Dermatology and Leprosy and Institute of STD, 
Madras Medical College, Chennai - 600 003, during the academic  year 2003 - 2006.  This 
work has not previously formed the basis for the award of any degree or diploma.
     Prof. Dr. B.PARVEEN, M.D.,D.D.,                                          
                             Professor and Head
    Department of Dermatology & Leprosy
    Madras Medical College,
    Chennai - 600 003.
                                                                                                                                      
Prof. Dr. Kalavathi Ponniraivan, B.Sc., M.D.,
The Dean,
Madras Medical College,
Chennai.
Prof.Dr.V.S.DORAIRAJ, M.D. D.V.,
Director Incharge,
Institute of STD,
Madras Medical College,
Chennai - 600 003.
SPECIAL ACKNOWLEDGEMENT
My sincere  thanks  to  Prof.  Dr.  Kalavathi  Ponniraivan,  B.Sc.,  M.D., the  Dean, 
Madras Medical College for allowing me to do this dissertation and utilize the institutional 
facilities.
ACKNOWLEDGEMENT
I  am  gratefully  indebted  to  Dr.V.S.Dorairaj,  M.D.,  D.V., Director  Incharge,  Institute  of 
Venereology for his invaluable guidance, motivatino and help through out the study. I would like to 
express  my sincere  and heartfelt  gratitude  to  Dr.Dr.N.Usman,  M.D.,  D.V.,  Ph.D., former  Director, 
Institute  of  STD  and  former  and  former  Professor  and  Head  of  Department  of  Dermatology 
Dr.N.Gomathy, M.D., D.D.,  for their constant support and motivation. I wish to thank  Dr.S.Mohan, 
M.D., D.V., Registrar, Institute of STD for his support. 
I am very grateful Dr.B.Parveen, M.D., D.D., Professor and Head of Department of Dermatology 
for her invaluable guidance and help. I sincerely thank Dr.C.Janaki, M.D.,D.D., Reader of Dermatology 
(Mycology) for her support.
I  express  my  earnest  gratitude  to  Dr.D.Prabavathy,  M.D.,D.D., Professor  and  Head  of 
Department  of  Occupational  Dermatology  and  Contact  Dermatitis  for  her  constant  motivation  and 
guidance. I thank Dr.V.Somasundaram, M.D.,D.D., Additional Professor, Department of Occupational 
Dermatology and Contact dermatitis for his kind help and support.
I  express  my  sincere  gratitude  to  Dr.K.Rathinavelu,  M.D.,D.D.,  Professor  of  Leprosy  and 
Dr.R.Arunadevi, M.D.,D.D., Lecturer / Registrar, Department of Dermatology for their support.
I  wish  to  thank  Dr.S.Venkateshwaran,  M.D.,  D.V.,  Dr.Ilangovan,  M.D.,  D.V., 
Dr.Thilagavathy,M.D.,  Dr.Thirunavukkarasu,  M.D.,  D.V.,  Dr.Ramachandra Reddy,  M.D.,  D.V., 
Dr.P.Mohan, M.D. D.V., and Dr.S.Arunkumar, M.D., D.V., Assistant Professor, Institute  of STD, for 
their help and suggestions.
My sincere thanks go to  Dr.R.Priyvathani, M.D.,D.D.,D.N.B., Dr.V.Anandan, M.D., (Derm), 
D.Ch., D.N.B., (Ped), and  Dr.K.Tharini, M.D.,  Assistant Professors Department of Dermatology for 
their kind support and encouragement.
I  thank  Dr.A.Hameedullah, M.D., D.D., Dr.Kumaravelu, M.D., D.D.,  and  Dr.J.Manjula, 
M.D., D.N.B (Derm) Assistant Professors for their support and help.
I  am  also  thankful  to  Dr.Senthamilselvi,  M.D.,D.D.,  MNAMS,  Ph.D.,  Dr.K.Manoharan, 
M.D.,D.D., and Dr.V.Sampath, M.D.,D.D., for their continuing guidance and support.
I duly acknowledge the paramedical staff and my colleagues for their help and favours.
Last but not least I am profoundly grateful to all patients for their cooperation and participation in 
the study.
CONTENTS
Sl. No. Title Page 
No.
I INTRODUCTION 1
II REVIEW OF LITERATURE 2
III AIMS OF THE STUDY 31
IV MATERIALS AND METHODS 32
V OBSERVATIONS 33
VI DISCUSSION 55
VII CONCLUSION 61
BIBLIOGRAPHY
PROFORMA
INTRODUCTION
There is strong epidemiological association between HIV infection and syphilis. Both 
disease are predominantly sexually transmitted and syphilis patients are at increased risk for 
HIV infection.
In HIV infected persons, it has been reported that syphilis shows atypical clinical and 
serological  courses,  unreliable  response  to  therapy  and  premature  development  of 
neurosyphilis. 
Its  is  well  documented  that  prevalence  of  STD favours  transmission  of  HIV in  the 
community and control of STD has brought down the transmission of HIV to 42% according to 
Mwanza study1.
This study is designed to compare the epidemiological, clinical presentation, serological 
variation  of  syphilis  and  other  associated  STDs in  presence  of  HIV infection  and in  HIV 
negative patients in our setting.
REVIEW OF LITERATURE
Definition2
Syphilis was defined by stokes, as an infectious disease, due to Treponema Pallidum of 
great chronicity, systemic from the outset, capable of involving practically every structure of 
the body in its course, distinguished by florid manifestations on the one hand and years of 
completely asymptomatic latency on the other, able to simulate many disease in the field of 
medicine and surgery, transmissible to off - spring in man, transmissible to certain laboratory 
animals and treatable to the point of presumptive cure.
History of Syphilis3
There  are  two  theories  regarding  the  origin  of  syphilis.  One  the  Unitarian  theory, 
according to which the disease originated in the tropics as a primitive treponemal disease and 
later  spread  to  more  temperate  climates  affecting  more  advanced  communities  where 
transmission by sexual contact became the usual mode of spread of disease. 
The other theory is columbian theory, according to which the disease was brought to 
Europe with the return of columbus in 1493 after his discovery of America from Europe the 
disease spread to India and far East through portuguese sailors.
The disease acquired its name from a poem "Syphilis Sive Morbus Gallicus' written in 
1530  by  an  Italian  Pathologists  Giralamo  Fracostaro  about  an  infected  mythical  shepherd 
named syphlicus afflicted with the french disease as punishment for cursing the gods.
In  18th  century  (1728  -  1793)  John  Hunter  of  London  believed  that  syphilis  and 
Gonorrhoea are different manifestations of same infection. To test the validity of this theory he 
obtained pus from patient with gonorrhoea and inoculated himself. It was most unfortunate that 
the  inoculam was  contaminated  with  the  causative  organism of  syphilis  as  well,  and  both 
syphilis and gonorrhoea developed in typical fashion.
The view that syphilis and gonorrhoea were different diseases was firmly established by 
Ricord  in  1838.  Fritz  Schaudiam  and  Erich  Hoftmann  in  1905  discovered  the  spirochete 
organism in serum from a lesion of secondary syphilis. They reported that syphilis was caused 
by a spirochete which they named "Spirochaeta Pallida".  this  work was quickly confirmed 
when Karl Landsteiner introduced the dark field method for the detection of the organism in 
1906. In 1906 wasserman of Berlin described complement fixation test for syphilis.
In 1943, penicillin which was discovered by Sri Alexander Fleming and developed by 
Florey in oxford, was successfully used by Mahoney and his colleagues to treat syphilis. In 
1946, Harris et al., described the VDRL  slide flocculation test.
Epidemiology
Syphilis being on ulcerative disease, occurs all over the world without any restriction to 
any social class. Every case of infectious syphilis should be considered as a potential source of 
infection.  It  is  a  major  cause  of  Genitourinary  disease  and an important  risk factor  in  the 
transmission of HIV Infection.  In developed countries  the prevalence of syphilis has fallen 
steeply  due  to  improved  access  to  health  care  and  effective  treatment.  But  in  developing 
countries like India, it still remains a public health problem.
The factors that operate and interact in acquisition and spread of the disease are complex 
in nature. Sexual promiscuity and prostitution are the twin menaces around which revolve other 
factors.  The  population  explosion,  migration  of  people  from  rural  to  urban  areas, 
disproportionate male to female ratio in urban and pilgrim centres, the mushrooming growth of 
slums in the cities and towns leading to overcrowding with lower socioeconomic status, decline 
in  moral  values,  ignorance  and lack of  sexual  education  all  account  for  the  spread of  the 
disease. The social stigma attached to a sexually transmitted diseases leads to its concealment 
and aids its  spread.  The cinema,  magazines,  wall  posters,  exhibits,  advertisements  etc  also 
encourage promiscuity4.  Association between high risk behaviour  pattern  and syphilis  well 
documented. Extramarital sexual activity, disharmony with spouse, premarital sex, multiple sex 
partners, non usage of condoms, visiting commercial sex workers are important risk factors.
In India, prostitution is still an important cause for the spread of STDs. Economic factors 
play a considerable role in prostitution particularly among the underprivileged. Syphilis was the 
commonest STD affecting 30% of 200 prostitutes attending a clinic for various ailments5.
A country's socio - economic structure and its functioning determines the prevalence of 
syphilis  in a  community.  In  India  as  well  as  in other  developing countries,  poor  reporting 
systems make it difficult to obtain the exact incidence and prevalence of syphilis. The reported 
incidence of early syphilis among STD patients in India declined from 61.2% in 1954 to 9.1% 
in 1994. Syphilis is the commonest STD in India and accounted for 10.4% to 36.1%6. As per 
serological  surveys its  prevalence ranges from 2.66 to 26.6%7 syphilis  is  more common in 
males than in females and more common in 20 - 40 years, sexually active age group. It has 
been observed that majority of males continue to be sexually active even after acquiring the 
infection. Alcohol and drug abuse are additional risk factors. 
Microbiology8,9
Treponema Pallidum is a thin, delicate spirochete with tapering ends, about 8 - 16 µm 
long and 0.1 - 0.2 µm wide. It has about 6 - 20 regular spirals, sharp and angular at regular 
interval of about 1 µm. It is actively motile exhibiting rotation around long axis, backward and 
forward movement, the whole body is flexible. Other movements are buckling, undulating, coil 
compression and expansion, angulation and looping. The organism divide by binary fission.
Electron Microscope8
The cytoplasm surrounded by trilaminar cytoplasmic mambrane, enclosed by a cell wall 
containing peptidoglycan which gives cell rigidity and shape. External to this is lipid rich outer 
membrane layer, through which only a few antigenic proteins protrude (TROMP) from each 
end of cell. There is 3 - 4 endoflagella wind around axis of cell but do not protrude outside, 
remain  with  in  outer  membrane  layer.  The  highly  immunogenic  portions  of  organism are 
lipoprotein anchored predominantly to periplasmic leaflet of cytoplasm membrane.
Cultivation
Pathogenic T.P. do not grow in artificial media. Virulent T.P. strains are maintained for 
decade by serial testicular passage in rabbits (Nichol Strain). This is used for diagnostic and 
research purpose. The isolate of non - pathogenic T.P (Reiter Strain) is used as Antigen in 
group  specific  treponemal  test  for  diagnosis  of  syphilis.  The  reiter  strain  grow  well  on 
thioglycollate medium containing serum.
Resistance
Treponema pallidum is very delicate, inactivated by drying or at the temperature of 41 - 
42ºC in one hour which is the basis for fever therapy. It is killed in 1 - 3 days at 0 - 4ºC. 
Inactivated by contact with O2, distilled water, soap, arsencial, mercurial, bismuch and common 
antiseptic agents.
Pathogenesis10
The complex host - microbe interactions that characterise the varied  clinical course of 
syphilis are poorly understood. Treponema Pallidum penetrate through small breaks in skin or 
mucosa.   The generation time of  T.Pallidum during early  active stage is  30 -  33 hrs.  The 
concentration of Treponemes generally reaches at least 107/g of tissue before the appearance of 
a  clinical  lesion.  The  median  incubation  period  in  human  is  21  days  suggests  an  average 
inoculam of 500 - 1000 infections organisms.  The infectious dose for 50% of individuals to 
develop the disease is 57 organisms. After penetration, the organism slowly multiplies at the 
site of inoculation and forms a primary chancre. Both CMI and humoral antibody response 
occurs against T.Pallidum. CMI causes tissue damage mainly by recruitment of lymphocytes 
(CD8  +  CD4  +  cells),  Plasma  cells  and  macrophages  resulting  in  capillary  endothelial 
proliferation and subsequently endarteritis obliterans resulting in primary chancre. Due to TH1 
-  type  cytokine  profile,  macrophages  are  activated  leading  to  phagocytosis  and  ultimately 
destruction of treponemes, resulting in spontaneous resolution of chancre. But due to partially 
exposed immunogenic  surface  proteins,  (TROMP)11 treponemes persists  resulting  in  partial 
immunity  and  dissemination  of  infection,  through  blood  and  lymphatics  long  before  the 
appearance of primary lesions. Humoral responses lead to development of cross reacting non - 
specific (non - treponemal) antibodies.
Clinical Classification of Syphilis
Early Syphilis
Primary
Secondary
Early Latent
Primary Syphilis2,9
After an incubation period of 9 - 90 days (mean 21 days), Infection starts as a macule, 
becoming papule subsequently ulcerates to form a chancre. In men common sites are coronal 
sulcus,  glans,  shaft  of  penis,  prepuce,  frenulum,  urinary  meatus.  In  women vulva,  vagina, 
cervix12 are the common sites. The physical characteristics of primary chancre are.
Single, Indurated, painless ulcer with sharply defined border. Exudate is serous. Base 
tends  to  be  clean  with  a  faint  greyish  pellicle.  A  painless  non  -  inflammatory,  discrete 
enlargement of the adjacent lymph nodes usually bilateral develops after the appearance of the 
lesion. Two third of cases on healing leaves thin atrophic invisible scar. Extra genital chance 
occurs on Anorectal, oral cavity, breast, hands, fingers, nails etc.
Condom chancre - chancre occuring at hilt of shaft of penis.
Chancre redux  - recurrence of primary sore at site of original lesion13
Pseudo chancre redux - Gumma occuring at site of primary sore
Follman's balanitis - Inflammatory reaction of glans in primary syphilis.
Syphilis d'emblee14 - Syphilis without chancre due to direct inoculation as a result of 
blood transfusion.
The primary lesions will heal within three to ten weeks and may go unnoticed by the 
patient.
Secondary Syphilis2,9,15
The lesions of secondary syphilis usually occurs 4 - 8 weeks after the appearance of 
primary chancre. In about one third of cases, primary lesions is still present. The lesions are 
generalised and can involve any organ. Although skin rash and lymphadenopathy are the most 
common manifestation more than 60% doesn't recall any type of lesions16.
The  rash  may  be  macular,  papular,  maculopapular,  papulosquamous,  psoriasiform, 
annular,  pustular,  nodular,  lichenoid or follicular17.  Vesiculobullous lesions do not occur in 
adults. Rash in Generalised, non itchy, bilateral and symmetrical involving Trunk, extremities, 
palms and soles. Face is usually spared. Papules along hairline on forehead arranged in a crown 
like  pattern  called  corona  veneri.  Follicular  type  associated  with  pruritus  and  can  go  for 
neurosyphilis.  Corymbose  syphilid  characterised  by  central  plaque  surrounded  by  smaller 
satellite papules. Buschke ollendorf sign - deep dermal tenderness elicited by applying pressure 
with blunt side of pin over a papule. In warm and moist areas of body like Genitals, perineum, 
perianal, under breast, axilla, groin, the lesions may proliferate to form broad based flat topped 
papules.
Mucous lesions in the form of serpigneous ulcers called as snail track ulcers, erosions, 
split papules affecting oral and genital mucosa.
Motheaten alopecia beginning in the occipital hair is characteristic. Loss of eyelashes 
and lateral 1/3 of eyebrow may occur.
Lymphadenopathy involving two or more groups are discrete, rubbery, painless and non 
tender. The occipital, axillary, inguinal, epitrochlear group of lymph nodes are most commonly 
involved.
Systemic  manifestations  include  fever,  malaise,  mild  hepatitis  with  elevated  liver 
enzymes,  icterus,  uveitis,  arthritis,  parotids,  pulmonary  changes,  periostitis,  glomerulo 
nephritis,  myocarditis,  neurological  involvement  can  occur  but  mostly  are  asymptomatic. 
Untreated secondary syphilitic rash can last several weeks. Relapse can occur in 25% cases. 
The severity of relapse is less severe than initial episode.
LATENT SYPHILIS
Latent  syphilis  defined  as  reactive  serology  along  with  positive  specific  trepenemal 
Antigen tests in the absence as well as adequate treatment. 2 year period (WHO), 1 year period 
(CDC)  guidelines  considered  demarcation  between  early  and  late  latent  syphilis.  This  is 
important,  as  patients  in  early  latent  stage  may  have  relapse  of  secondary  syphilis  and  is 
considered infectious.
LATE SYPHILIS
Classified as
1. Late latent
2. Late Benign
3. Tertiary syphilis - CVS
- Neurosyphilis
Late Benign Syphilis10
Manifests commonly as Gumma. The lesions are due to cellular hypersensitivity to few 
treponemes. Histologically show a granulomatous inflammation with central area of necrosis. 
The most commonly involved sites include skin and skeletal system, mouth, upper respiratory 
tract, larynx, liver, stomach. However any organ can be affected.
Skin  lesions  may  be  solitary  or  multiple,  painless  and  indurated  nodular, 
papulosquamous and ulcerative lesions which are destructive, chronic tend to heal centrally and 
extend peripherally. Skeletal Gumma most frequently involves long bones of legs, but any bone 
can be affected. In late benign syphilis, serological tests are almost reactive and usually at high 
titre.
TERITARY SYPHILIS
NEURO SYPHILIS10
After  acquiring  the  infection,  spirochetes  frequently  invade  the  meninges  early  in 
infection within 3 -  18 months of  infection,  eventhough neurosyphilis  considered as a  late 
manifestation.
CNS involvement classified by Merrit et al.,18 as 
1. Asymptomatic  Neuro  Syphilis  :  Characterised  by  CSF  abnormalities  (ie) 
positive CSF VDRL, increased cell count, occasionally increased protein without symptoms or 
signs of neurological involvement.
2. Meningeal Syphilis :  Onset usually less than 1 year after acquiring infection 
involve either brain or spinal cord and presents with headache, nausea, vomiting, neck stiffness, 
cranial nerve involvement, seizures and changes in mental status. Those presenting with uveitis 
or iritis frequently have meningeal syphilis.
3. Meningovascular syphilis :  Occurs 5 to 10 years after infection. The disease 
reflects  diffuse  inflammation  of  pia  and  arachnoid  together  with  evidence  of  focal  or 
widespread arterial involvement. Common presentation is stroke syndrome involving middle 
cerebral artery often manifesting as subacute encephalitic syndrome.
4. Parenchymatous syphilis 
a. General paresis of insanc
Occuring  15  -  20  years  after  infection.  The  disease  reflect  widespread  late 
parenchymal damage; including abnormalities of personality, affect, hyperactive reflexes, AR 
pupil, Altered sensorium, decrease in recent memory and speech.
b. Tabes dorsalis
The disease due to demyelination of posterior column, dorsal root, dorsal root ganglia. 
Usually  occuring  25  -  30  years  after  infection.  Symptoms include  ataxic  wide  based  gait, 
paresthesia,  bladder  disturbances,  impotence,  areflexia  and loss  of  position,  deep  pain  and 
temperature sensation. Charcot Joint (Trophic Joint degeneration), perforating ulceration of feet 
and a small irregular Argyll robertson pupil react to accommodation and not to light.
Other  findings  include  syphilitic  optic  atrophy,  spinal  cord  involvement  and  nerve 
deafness.
Cardiovascular Syphilis19
Infection usually occurs after 10 - 40 years. Starts as an arteritis in the supra cardiac 
portion of aorta and progresses as follows :
- Narrowing of coronary ostia with decreased coronary circulation, Angina and MI.
- Scarring  of  Aortic  valves  producing  Aortic  regurgitation  and  eventually 
congestive cardiac failure.
- Due to median necrosis of aorta with saccular Aneurysm formation and associate 
pressure  symptoms  of  dysphagia,  hoarseness,  brassy  cough,  back  pain  and 
rupture of aneurysms.
Aortic insufficiency with no other valvular lesions in a person of middle age with a 
reactive serologic test should be considered cardiovascular syphilis until proven otherwise.
Lab Diagnosis of Syphilis20
Lab diagnosis for syphilis have been divided into 4 catogaries. 
1. Direct  microscopic  identification  of  organism  from  lesions  of  primary  and 
secondary syphilis by :
i. Dark field examination 
ii. Direct fluorescent Antibody test.
2. Serological tests to detect IgG Antibodies.
a. Non treponemal test
These are useful for screening purposes, however they can be confirmatory when 
titres are high.
VDRL (Venereal Disease Research Laboratory)
It  is  a  slide  flocculation  test.  This  test  having a  standardised  antigen comprising  of 
lecithin, cholesterol, purified cardiolipin to detect antigen against cardiolipin. As antigen used 
is  present  in  all  mammalian tissue,  the damage to  host  tissue of   infection,  immunization, 
pregnancy, age related changes of autoimmune disease can result in False positive VDRL test21. 
This reactivity will be usually in low dilution < 1:8. Biological false positive can be acute < 6 
months, chronic > 6 months. HIV is an important cause of biological false positive22. Prozone 
phenomenon is  an  immunological  event  seen with  VDRL.  In  this  due to  Antibody excess 
(Blocking Ab) false negative test result will occur23.  This is more common in patients with 
secondary syphilis and HIV infection. VDRL titre in primary syphilis will be < 1:8 upto 1:16 
secondary syphilis > 1:32, latent and tertiary stage titre will be low.
CSF Examination24
CSF is a sensitive indicator of presence of active neurosyphilitic infection. The CSF 
abnormalities are :
Cell Count : More than 5 lymphocyte is abnormal
Total Protein : More than 40 mgs% usually abnormal
CSF VDRL : A reactive spinal VDRL is always a indication of CNS syphilis, but 
not necessarily of its activity. False positive reactions in spinal fluid are rare.
Increase in gammaglobulin (IgG); usually with oligoclonal banding.
The Glucose count is  usually normal.  In general,  the cell  count may be expected to 
return first to normal followed by protein and finally the serological test.
ii. Specific Tests
1. Treponema pallidum immobilization test (TPI)
2. Treponema palldium hemagglutination assay (TPHA)
3. Fluorescent Treponemal antibody absorption test (FTA-Abs)
4. Micro hemagglutination assay for T.pallidum (MHA-Tp)
5. Teponema palldium particle agglutrination test  (TPPA)
6. ELISA.
7. Western blot
3. Direct Ag detection test - polymerase chain reaction (PCR)
4. Detection of T.Pallidium IgM Antibody
5. Tissue section
- Fontana 
- Levaditi
All HIV positive patients with late latent syphilis or latent syphils of unknown duration 
should undergo CSF examination.
Treatment25
Goals  of  therapy are to prevent transmission and avoid late complications for  Early 
infectious syphilis, both the patient and partner to be treated with single dose Inj. Benzathine 
Pencillin. 24 lakhs units IM (Or) Inj. Procaine Pencillin 12 lakh IM daily x 10 days. For late 
latent,  gummatous  and  cardiovascular  syphilis.  Inj.  Benzathine  Pencillin  24  lakh  units  IM 
weekly x 3 weeks.
(or)
Inj. Procaine Pencillin 12 lakhs units im daily x 21 day.
In patient allergic to pen. G. alternate therapies are :
C. Tetracycline 500 mg Q1D
C. Doxy 100 mg Ibd x 14 days for 
T.Erythromycin 500 mg Q1D early syphilis and 
T.Azthiromycin 500 mg 1OD 28 days for late syphilis
For Neurosyphilis / ocular Syphilis
Inj. Procaine Pen. G. 1.2 - 2.4 mega units + probenacid 500 mg Q1D daily for 10 - 14 
days. Treatment for neurosyphilis in patients sensitive to pencillin G is to desensitize and give 
penicillin.
Treatment in HIV (+) Patients26
According to WHO guidelines, treatment is same as that of HIV negative individuals, 
but more frequent serological and clinical follow up to be done at 3, 6, 9, 12 & 24 months post 
treatment. 
AIDS
INTRODUCTION27
Acquired immunodeficiency syndrome (called slim disease) is a fatal illness caused by a 
retrovirus  known as  HIV which  breaks  down the  body  immue system,  leaving  the  victim 
vulnerable  to  a  host  of  life  threatening  opportunistic  infection,  neurological  disorder,  and 
unusual malignancies. HIV once infected will be infected for life. The term AIDs refers onlyto 
the  last  stage  of  HIV infection.  AIDs  can  be  called  modern  pandemic  affecting  both  the 
developed and developing countries.
HISTORY28,29
* AIDs was first identified from New York and Los Angeles in 1981 from patients 
suffering from Kaposi  Sarcoma and Penumocystis  carini  pneumonia in  young 
homosexuals.
* In 1983, Luc Montagnier and colleagues, from paris isolated a retrovirus from 
patient  with  persistent  generalised  lymphadenopathy  and  called  as 
lymphadenopathy associated virus.
* In 1984, Robert Gallo, USA isolated the virus from AIDs patients and called it as 
HTLV 3.
* In 1985, ELISA was introduced for detection of HIV antibodies.
* In 1986 - First case was identified in India, Chennai.
* In 1987 - Zidovudine was introduced.
* In 1991 - HIV 2 was identified in India, Bombay.
EPIDEMIOLOGY30
HIV / AIDs is a global pandemic, with cases reported from virtually every country. The 
global estimate of cases in 2003 among adult is 37 million, 2/3 of them in subsaharan Africa. In 
addition 2.5 million cases of children are living with HIV / AIDs. In 2003 alone, 5 million new 
cases of infection worldwide and 3 million deaths from AIDs has been reported. It is estimated 
that  every 12 seconds a young person somewhere in the world acquire HIV infection,  and 
14,000 new HIV infections occur each day. 
INDIA
India is now considered the country with the largest number of HIV infected persons in 
the  world,  5.1  million  in  2004.  The  epidemic  is  spreading  primarily  through  heterosexual 
relations. The most rapid and well documented spread of HIV has occurred in Mumbai and 
Tamil Nadu. In Mumbai, according to some studies, HIV prevalence has reached the level of 
50% in sex workers,  36% in STD patients  and 2.5% in women attending antenatal  clinic. 
Intravenous drug abuse is a problem in Manipur, where 55% of drug users are HIV infected 
and 1% of women attending antenatal clinics are infected with HIV. HIV is rapidly spreading 
to rural areas through migrant workers and truck drivers. Surveys show that 5 - 10% of some 
truck  drivers  in  the  country  are  infected  with  HIV.  As  estimated  1  -  2  million  cases  of 
tuberculosis occur in India every year. In Mumbai 10% of the patients presenting with TB are 
HIV  positive.  In  Tamilnadu,  almost  half  a  million  people  are  infected  with  HIV and  the 
infection rate is three times  higher in villages than in the cities.  In India HIV epidemic is 
shifting from high risk population to general population.
WHO CLINICAL CASE DEFINITION FOR AIDS31
AIDs in an adult is defined by the existence of atleast 2 of the major signs associated 
with atleast one minor sign, in the absence of known causes of immunosuppression such as 
cancer or severe malnutrition or other recognized etiologies.
Major Signs
* Weight loss >10% of body weight
* Chronic diarrhoea > 1 month
* Prolonged fever >1 month (intermittent / constant)
Minor signs
* Persistent cough > 1 month
* Generalizied pruritis dermatitis
* Recurrent herpes zoster
* Oropharyngeal candidiasis
* Chronic progressive and disseminated Herpes simplex Infection
* Generalised lymphadenopathy
The presence of generalised Kaposi's Sarcoma or cryptococcal meningitis is sufficient 
by itself for the diagnosis of AIDs.
WHO STAGING SYSTEM FOR HIV INFECTION32
Clinical State I
* Asymptomatic
* Persistent generalized lymphadenopathy
* Performance scale 1 : asymptomatic, normal activity 
Clinical Stage 2
* Weight loss <10% body weight
* Minor mucocutaneous manifestation (seborrheic dermatitis prurigo, fungal nail 
infections).
* Herpes zoster within last 5 years.
* Recurrent upper respiratory infection (bacterial sinusitis)
* Performance scale 2 : symptomatic, normal activity.
Clinical Stage 3
* Weight loss > 10% body weight
* Unexplained chronic diorrhoea > 1 month
* Unexplained prolonged fever (intermittent or constant > 1 month)
* Oral candidiasis (thrush)
* Oral hairy leucoplakia
* Pulmonary tuberculosis within the last year
* Severe bacterial Infection (Penumonia, Pyomyositis)
* Performance scale 3 : bed ridden <50% of the day during last month.
Clinical Stage 4
* HIV  wasting  syndrome  (weight  loss  >10%  plus  either  unexplained  chronic 
diarrhoea > 1 month or chronic weakness and unexplained prolonged fever > 1 
month).
* Pneumocystis carinii penumonia.
* Toxoplasmosis of the brain
* Cryptosporidiosis with diarrhoea > 1 month
* Cryptococcosis extrapulmonary
* Cytomegalovirus of an organ other than liver, spleen or lymph nodes.
* Herpes simplex virus infection, mucocutaneous >1 month or visceral.
* Progressive multifocal leucoencephalopathy (PML)
* Any disseminated endemic mycosis (i.e.) histoplasmosis, coccidioidomycosis.
* Candidiasis of oesophagus, trachea, bronchi or lungs.
* Atypical mycobacteria, disseminated.
* Non typhoid salmonella septicemia.
* Extra pulmonary tuberculosis
* Lymphoma
* Kaposi sarcoma
* HIV encephalopathy
* Performance scale 4 : bed ridden >50% of the day during the last month.
LAB DIAGNOSIS OF HIV INFECTION - Immunological Test32
       Specific Tests28.
* Haemoglobin - progressive reduction over time 10-20% of asymptomatic HIV + 
people are anaemic Vs 70% of AIDs patients.
* Leucocyte  count  -  progressive  reduction  over  time.  Leucopenia  in  10%  of 
asymptomatic to 65% of AIDs patient.
* Platelet count - reduced in approximately 10% of asymptomatic and in upto 45% 
of AIDs patient.
* Neutrophil count - reduced in 20 - 50% of AIDS patient.
* Lymphocyte  count  -  reduced  in  70%  of  AIDs  patients  with  opportunistic 
infections.
* CD4 count - progressive reduction over time. 
* CD8 + lymphocyte - initially increases, falls later
* CD4 / CD8 Ratio - progressive reduction over time
* LFT - abnormal in 90% but usually mildly, often less than or equal to 2 times the 
upper limits of normal.
* Serum globulins - Hypergammaglobulinemia (polyclonal).
* HB surface antigen - present in approximately 10% of patients.
* Treponemal antibody test - positive in upto 45% of HIV infected homosexual 
men.
Specific Tests for HIV
These include demonstration of HIV, its antigens, or other components and antibodies 
(or) virus isolation.
* Antigen detection
- P24 Ag assay
- P24 Ag capture assay (ELISA)
* Virus isolation
* PCR - specific test for diagnosis in all stages of HIV infection
* Antibody detection
This is the commonly used test for diagnosis of HIV infection. As antibodies are not 
produced during seroconversion, these tests are not useful in the window period.
- ELISA - Screening test
- Western Blot - Confirmatory test
* Other fluid tests
- Oral (salivary) HIV Ab EIA (orasure)
- Urine Ab EIA (Calypte HIV - 1 Urine EIA)
Treatment Modalities Available for HIV / AIDs Objectives of the therapy33
- Prolonging life and improving quality of life 
- Reduction of viral repliation as much as possible for as long as possible to half 
disease progression and to prevent opportunistic infections and malignancies and 
- To achieve reduction in HIV transmission.
ANTI RETROVIRAL DRUGS
i. Nucleoside Reverse Transcriptase Inhibitors
ii. Non nucleoside reverse transcriptase inhibitors
iii. Protease inhibitors
iv. Fusion Inhibitor
No mono - therapy  or dual therapy (Except in PPTCT and PEP). Use three or more 
drugs and always watch for resistance to drugs.
SYPHILIS AND HIV
Both STD and HIV predominently have the same route of transmission (i.e) the sexual 
route34.
* Risk behaviour in individuals predisposed to STD and HIV just the same.
* Presence of other STIs make it easier for HIV to be transmitted from one partner 
to others.
* Infection  with  HIV  affects  other  STIs  by  making  them  more  resistant  to 
treatment.
* Genital ulcers having 5 - 10 fold increase in risk of transmission of HIV.
Coinfection with syphilis, is strikingly common in HIV infected persons. Some studies 
report syphilis seroprevalence >30% in HIV positive patients35,36. Syphilitic genital ulcers are 
cofactors for bidirectional transmission of HIV. Virulent Treponema pallidum and its abundant 
membrane lipoproteins induce HIV - 1 gene expression and production in chronically infected 
macrophages  leading  to  the  progression  of  HIV  infection.  HIV  infection  reduces  the 
immunologic responses to Treponemal infection, both cell mediated and Humoral immunity, 
which  impairs  the  host  defence  against  syphilis  and  facilitate  its  progression.  Transient 
immunosuppresion during early stages of syphilis has a similar effect on host defences against 
HIV,  leading  to  a  synergistic  immunosuppressive  state,  which  could  allow either  agent  to 
penetrate earlier into central nervous system.
In the presence of HIV infection, the clinical and serological natural history of syphilis 
may  be  altered,  response  to  treatment  may  be  less  than  expected  and  an  increase  in  the 
incidence of neurosyphilis has been noted.
Coexistent HIV infection modifies syphilitic genital ulcer manifestations, like multiple 
primary chancre, extra genital chancre more frequently37. Secondary syphilis with concurrent 
primary  chancre  is  more  common  in  HIV  infected  persons,  persistant  chancres,  rapid 
progression from primary to secondary syphilis,  with florid signs and symptoms, including 
syphilis maligna characterised by noduloulcerative skin lesions, necrotising vasculitis, systemic 
symptoms, high VDRL titre have been recorded38. High persistent non treponemal titres as well 
as delayed serological responses to infection with Treponema pallidum, delayed regression to 
normal  non  -  reactive  levels  after  apparently  adequate  treatment  and  an  unusually  high 
incidence of biological  false positive results  have been observed. Neurosyphilis  may be an 
early infectious complication or even the presenting one, in patients who subsequently develop 
AIDs39.
PREVENTION AND CONTROL OF HIV / AIDS
It is done by
1. Surveillance
2. Counselling, health education and condom promotion
3. Blood safety by standardising blood banks
4. Protection of health care workers by following universal precaution
5. Early treatment of STD
The principles on how to bring about behavioural change and to sustain it needs to be 
intensely studied. Then only we can be more successful in our current efforts of HIV control40.
AIMS OF THE STUDY
1. To study Age and Sex distribution in HIV positive patients.
2. To study Risk factors involved in transmission of syphilis in HIV positives.
3. To study the clinical presentation of syphilis in HIV individuals
4. To assess VDRL titre in HIV (+) and HIV (-) syphilitic patients
5. To study other STD's occuring along with syphilis in HIV positive and Negatives.
MATERIALS AND METHODS
Study Design
Prospective observational study.
Sample
Patients  attending  the  STD  OPD  at  Institute  of  Venerology,  Government  General 
Hospital, Chennai from June 2004 to December 2005 formed the subject of this study.
Final list of subjects included 80 syphilitic patients, of which 40 were HIV positive and 
40 were HIV negative. There was no exclusion criteria.
METHODOLOGY
The  above  selected  patients  for  this  study  were  interviewed.  Their  presenting 
complaints,  sexual history, past history of anogenital disease and any treatment taken were 
elicited.  The  subjects  underwent  genital  and  complete  physical  examination.  Screening  for 
other sexually transmitted diseases (as seen in annexure) was done. Routine laboratory tests 
and serological investigations were done, which included Blood VDRL and TPHA. ELISA for 
HIV - 1, 2 antibody (Serum is submitted to dilution to overcome prozone phenomenon) assay 
was done after informed consent and providing present and post test counselling at VCTC.
CRITERIA FOR DIAGNOSIS
a. HIV infection
- ELISA for HIV 1 and Antibodies (Strategy III is followed)
- Confirmation by western blot if necessary.
b. Primary syphilis
1. Clinical features
2. Positive dark field examination
3. Serology VDRL and TPHA
(Any one of the 2 and 3)
c. Secondary Syphilis
1. Clinical features
2. Dark field examination of treponema pallidum
3. Serology - VDRL and TPHA
(Any one of (2) and (3)
d. Cardiovascular syphilis
- Clinical features
- Serology - VDRL and TPHA
- CXR, ECG, ECHO, USG Examination
e. Neuro syphilis
- Clinical features
- Serology - VDRL and TPHA
- CSF VDRL
- Positive protein and lymphocyte pleocytosis.
CSF analysis was done i)  In patients with late latent syphilis of both HIV +ve and 
negative individuals and for those early syphilitic patient with clinical feature suggestive of 
neurosyphilis.
ii) For  patients  who gave their  consent for Lumbar puncture after explaining the 
risks.
In addition, the following investigations were done to diagnose other coexisting STD's.
In case of genital ulcers
- Gram staining for Ducreyi
- Tissue smear for CBG
- Leishman's staining for GEC
In case of discharge
- Gram staining for Gonococi
- Wet film for trichomonas vaginalis
- Wet film for candida
- KOH examination for Bacterial vaginosis
- Endocervical swab for smear and culture for gonococci.
In case of genital growth
- Biopsy of lesions
For all patients urine sedimentation done for Gonococci.
In addition, routine investigations like complete haemogram, RFT, LFT were done.
The  data  obtained  from  above  studies  were  analysed  and  the  results  reviewed  and 
discussed.
OBSERVATION
TABLE - 1 : SEX DISTRIBUTION
Sex HIV (+) % HIV Negative %
Male 22 55 24 60
Female 18 45 16 40
Analysis of sex distribution in this study shows that males are more commonly affected 
with syphilis in both HIV (+) and (-) patients.
TABLE - 2(a) : AGE WISE DISTRIBUTION OF HIV POSITIVE -VS - HIV 
NEGATIVE MALE PATIENTS
Age group
HIV Positive HIV Negative
n=22 % n=24 %
11-20 0 0 2 8
21-30 9 41 8 33
31-40 11 50 10 42
41-50 2 9 3 13
>50 0 0 1 4
Analysis of age distribution in males shows that most of the patients are in sexually 
active age group of 20-40 yrs in both HIV (+) 90% and (-) 75%  group. But both in HIV (+) 
and (-) group males commonly acquire syphilis during middle age period (ie) (31 - 40) age 
group.
TABLE - 2(b) : AGE WISE DISTRIBUTION OF HIV POSITIVE - VS - HIV 
NEGATIVE FEMALE PATIENTS
Age group
HIV Positive HIV Negative
n=18 % n=16 %
11-20 2 11 1 6.25
21-30 10 55.5 10 62.5
31-40 6 33.5 4 25
41-50 0 0 1 6.25
>50 0 0 0 0
Analysis of age distribution in Females shows, most of the patients are in sexually active 
age group (20 -  40 years) in HIV (+) 90% and HIV (-)  88% females are more commonly 
affected in (21 - 30) age group in both study group
TABLE - 3 : DOMICILE STATUS OF HIV POSITIVE - VS - HIV NEGATIVE 
PATIENTS
Domicile HIV Positive HIV Negative
M F % M F %
Rural 9 7 40 11 5 40
Urban 13 11 60 13 11 60
Domicile status of patients reveal that 60% of both HIV (+) & (-) patients hailed from 
urban areas compared to 40% from rural areas.
TABLE - 4(a) : MARITAL STATUS OF HIV POSITIVE - VS - HIV NEGATIVE MALE 
PATIENTS
Marital Status HIV Positive HIV Negative
n = 22 % n = 24 %
Married 15 69 16 67
Single 7 31 8 33
Majority of males (70%) in both HIV (+) and (-) group were married.
TABLE - 4(b) : MARITAL STATUS OF HIV POSITIVE - VS - HIV NEGATIVE 
FEMALE PATIENTS
Marital Status HIV Positive HIV Negative
n=18 % n=16 %
Married 7 40 10 62.5
Separate 3 16 2 12.5
Widowed 4 22 1 6.25
Kept 2 11 1 6.25
Single 2 11 2 12.5
In both HIV (-) and HIV Positive females (90%) are married. But a significant number 
were either widowed (22%), or separated from their husband (17%) (or) kept (11%) in HIV 
positive syphilitics.
TABLE - 5(a) : OCCUPATION OF HIV POSITIVE - VS - HIV NEGATIVE MALE 
PATIENTS
Occupation HIV Positive HIV Negative
n=22 % n=24 %
Labourer 2 9 5 21
Driver 8 36.5 4 17
Mason 4 8 3 12.5
Hotel Servant 3 14 5 21
Agriculture 1 4.5 2 8.5
Mechanical 1 4.5 1 4
Shop 0 0 1 4
MSM 2 9 2 8
Business 1 4.5 1 4
In  HIV  (+)  group,  Truck  drivers  (36.5%)  are  more  commonly  affected.  All  other 
working groups are more or less equally affected.
In HIV  (-) patients, all working groups are equally affected with syphilis.
TABLE - 5(b) : OCCUPATION OF HIV POSITIVE - VS - HIV NEGATIVE FEMALE 
PATIENTS
Occupation HIV Positive HIV Negative
n=18 % n=16 %
House wife 6 33 3 19
Building worker 2 11 2 12.5
Labourer 2 11 4 25
Business 1 5.5 1 6
Agriculture 3 17 4 25
CSW 3 17 2 12.5
Shopkeeper 1 5.5 0 0
A significant No. of HIV (+) are House wives (33%). In other working groups, all are 
more or less equally affected, both in HIV (+) and (-) patients.
TABLE - 6 : LITERACY RATE
Literacy HIV Positive HIV Negative
M F % M F %
Literate 18 12 75 19 11 75
Illiterate 4 6 25 5 5 25
Majority of patients (75%)  are literate in both HIV(+) and (-) group.
TABLE - 7 : SEXUAL HISORY - Males
Sexual History HIV Positive HIV Negative
n=22 % n=24 %
PMC 4 18.1 6 25
EMC 6 27.3 8 33
PMC & EMC 11 50 7 29
Denies 1 4.6 3 13
Majority of both HIV (+) and (-) men were promiscuous and failed to use condoms. 
Both premarital and Extramarital contact are more common in HIV (+) group 50% compared to 
HIV (-) 30%.
TABLE - 8 : MODE OF SEXUAL ACT - Males
Mode of sexual 
act
HIV Positive HIV Negative
n=22 % n=24 %
Heterosexual 16 72.7 17 70
Homosexual 3 13.6 2 8.5
Bisexual 2 9.1 4 17
IV Drug Abuse 1 4.6 1 4.5
Most  of  the  patients  are  heterosexuals  (70%)  both  in  HIV  positive  and  negative 
syphilitics.
TABLE - 9(a) PREVIOUS VENERAL DISEASE IN HIV POSITIVE - VS - HIV 
NEGATIVE MALE PATIENTS
Previous venereal 
diseases
HIV Positive HIV Negative
n=22 % n=24 %
Syphilis 5 22.7 2 8.5
Other genital ulcer 5 22.7 4 17
Genital discharge 3 13.7 1 4.2
Nil 9 40.9 17 70.3
H/o. previous genital ulcer (45%) disease is commonly seen in HIV (+) patients. No 
H/o.  previous  venereal  disease  reportingly  more  common in  HIV  negative  patients  (70%) 
compared to HIV positive syphilitics (40%).
TABLE - 9(b) PREVIOUS VENERAL DISEASE IN HIV POSITIVE - VS - HIV 
NEGATIVE FEMALE PATIENTS
 Previous venereal 
diseases
HIV Positive HIV Negative
n=18 % n=16 %
Syphilis 2 11 1 6.3
Vulvovaginal candidiasis 3 16.5 1 6.3
Bacterial vaginosis (BV) 1 5.5 2 12.5
Trichomoniasis (TV) 1 5.5 2 12.5
Cervicitis 0 - 1 6.3
Genital wart 1 5.5 0 0
Nil 10 56 9 56
Past history of Genital discharge (30%) was seen significantly in both HIV positive & 
negative  syphilitics,  >50% of  females  in  both  study  group  gave  no  previous  H/o  veneral 
disease.
TABLE - 10 : PRESENTING COMPLAINTS OF HIV POSITIVE - VS - HIV 
NEGATIVE PATIENTS
Presenting complaints
HIV Positive HIV Negative
M F % M F %
Check up 6 6 30 15 9 57.5
Genital ulcer 4 2 15 3 1 10
Genital discharge 1 5 15 2 4 15
Chest Pain 0 0 0 1 0 2.5
Skin rash 1 1 5 3 2 12.5
Loss of appetite 3 1 10 0 0 0
Cough 1 1 5 0 0 0
Fever 4 2 15 0 0 0
Diarrhea 2 0 5 0 0 0
Diminished vision 0 0 - 1 0 2.5
A  significant  number  of  HIV  (+)  males  and  females  (30%)  had  come  for  routine 
checkup compared to 58% in HIV negative group. Among both study group Genital ulcer and 
Genital discharge are the Chief presenting complaints in males and females respectively. HIV 
(+)ve  group  also  complained  of  various  constitutional  symptoms (35%)  like  fever,  cough, 
weight loss which was conspicuously absent among HIV (-) patients.
TABLE - 11 : PREVALENCE OF VARIOUS STAGES OF SYPHILIS IN AMONG HIV 
POSITIVE - VS - HIV NEGATIVE PATIENTS
Stage of Syphilis
HIV Positives HIV Negatives
No % No %
Primary 8 20 10 25
Secondary 8 20 9 22.5
Early Latent 13 32.5 14 35
Late latent 10 25 5 12.5
Benign Tertiary 1 2.5 0 0
CVS 0 - 1 2.5
Neuro 0 - 1 2.5
Early  syphilis  was  more  prevalent  among  HIV  (-)  Syphilitics,  SY  I  (25%),  SY  II 
(22.5%) ELS (35%) compared to HIV positive person. SY I (20%), SY II (20%), ELS (32.5%).
1 case of cardiovascular (2.5%) and 1 case of neurosyphilis (2.5%) found to be prevalent 
in HIV (-) group. 
TABLE - 12 : HIGH  VDRL TITRE IN VARIOUS STAGE OF 
SYPHILIS IN HIV POSITIVE AND NEGATIVE
Stage of Syphilis
High VDRL 
TITRE in HIV 
(+)
No. of 
Persons
High VDRL 
TITRE in HIV 
(-)
No. of 
Persons
Primary 1:64 2 1:16 2
Secondary 1:64 5 1:64 2
Early Latent (ELS) 1:32 4 1:16 2
Late latent (LLS) 1:8 1 1:8 2
Benign Tertiary 1:8 1 0 0
CVS 0 0 1:8 1
Neuro 0 0 1:32 1
High  VDRL titres  were  seen  among  HIV sero  positives  than  among  HIV negative 
persons. This was particularly evident among patient with early sphilis in primary 1:64 (25%), 
secondary 1:64(62.5%), ELS 1:32 (30%) compared to HIV (-) syphilitics primary 1:16 (20%), 
secondary 1:64 (22.5%), ELS 1:16 (15%).  Serological titre was high among HIV (-) 1:8 (42%) 
in late latent stage than HIV (+) 1:8 (10%).
TABLE - 13(a) ASSOCIATED DISEASES OF HIV POSITIVE 
- VS - HIV NEGATIVE MALE PATIENTS
Associated disease
HIV Positives HIV Negatives
n=22 % n=24 %
Gonorrhoea 1 4.5 1 4.2
Herpes Genitalis 3 13.5 1 4.2
Genital Warts 4 18 0 -
Chancroid 0 - 1 4.2
Molluscum contagiosum 3 13.5 1 4.2
Balanoposthitis 2 9 1 4.2
Nil 9 41.5 19 79
Among HIV (+)  males,  Genital  wart  (18%) was the most common associated STD. 
Other  STDs  like  Herpes  Genitalis  (13.5%),  molluscum  contagiosum  (MC),   (13.5%), 
Balanoposthitis (9%), found to be more common in HIV (+) males. No associated STD's (79%) 
was found in HIV (-) males compared to HIV (+) (42%).
TABLE - 13(b) : ASSOCIATED SEXUALLY TRANSMITTED DISEASES OF HIV 
POSITIVE - VS - HIV NEGATIVE FEMALE PATIENTS
Associated disease
HIV Positives HIV Negatives
No % No %
Trichomoniasis 2 11 4 25
Bacterial vaginosis 3 16.5 2 13
Vulvo Vaginal candidiasis 4 22 1 7
Genital Warts 1 5.5 0 -
Mollus cum contagiosum 1 5.5 0 -
Herpes Genitalis 2 11 0 -
Nil 5 28 9 55
Among  HIV  (+)  females,  vulvovaginal  candidiasis  (22%)  was  the  most  common 
associated STD.  Other  conditions,  like  bacterial  vaginosis  (16.5%),  genital  wart  (5.5),  MC 
(5.5),  Herpes  (11%)  found to  be  more  common in  HIV (+)  females.  In  HIV (-)  females, 
Trichomoniasis (25%) was the most common associated STD. No associated STD's (55%) was 
found in HIV (-) females compared to HIV (+) 28%.
TABLE - 14 : ASSOCIATED NON VENEREAL DISEASES IN HIV POSITIVE - VS - 
HIV NEGATIVE SYPHILITICS
Associated non venereal 
disease
HIV Positives HIV Negatives
No % No %
Oral candidiasis 7 17.5 0 -
Oral Hairy Leukoplakia 2 5 0 -
Dermatophytosis 5 12.5 1 2.5
Scabies 2 5 1 2.5
Herpes Zoster (HZV) 2 5 0 -
Pulmonary TB 1 2.5 0 -
Folliculitis 2 5 0 -
Nil 19 47.5 38 95
Non venereal diseases are more common in HIV (+) syphilitics, like oral candidiasis 
(17.5%) dermatophytosis  (12.5%),  scabies  (5%),  HZV (5%),  oral  hairy  leukoplakia  (OHL) 
(5%),  folliculitis (5%) in that order. HIV (-) syphilitics are not found to have any of these 
association.
DISCUSSION
In the present study, males are more commonly affected with syphilis in both HIV (+) 
and (-) patients. Similar to study with Rathore et al.,41 also majority of patients (90%) were in 
sexually  active  age group of  15 -  40 years.  Study  shows that,  males  are  more  commonly 
affected in age group of 30 - 40, while female patients are in 20 - 30 years. It was observed that 
60% of both HIV (+) males and females hailed from urban areas while 40% from rural areas. 
This indicates that HIV population has been on increasing side in rural population also. This 
finding is supported by reports of TANSACS.
70% of both HIV (+) and (-) syphilitic males were married. Observation showing 90% 
of  females  in  both  study  group  are  married,  but  a  significant  proportion  of  females  were 
widowed (22%), seperated from husband (17%) in HIV (+) group. Also most of the females 
commonly acquire infection from their partners in both HIV (+) and (-) group. Among females 
house wives (33%) and in males long run truck drivers (35%) are more commonly affected in 
HIV (+) group. Among HIV negative patients involving in other working groups like business 
people, mason, agricultural coolies, labourers, shop keepers are more or less equally affected. 
This  is  an indication that  both syphilis and HIV infection are more common among lower 
socioeconomic group, which needs to be taken care of. Majority of patients in both HIV (+) 
and (-) are literate, 75% among males, >50% among females. Taken into consideration of all 
these factors, there is a need to create awareness compaign about HIV/AIDS among high risk 
group like truck drivers and other low occupation groups and in rural areas. As many are found 
to be literate, a good awareness compaign can easily reach the people.
History of both premarital and extramarital contact were higher among HIV (+) males 
50% compared to 30% of HIV negative males. Majority of HIV (+) males are promiscuous and 
many of them had not used condoms. Higher incidence of sexual promiscuity and non usage of 
condoms among males, highlights the need for education about safe sex. Most of the females 
(>70%)  denies  H/o  premarital  or  extramarital  contact.  The  commonest  mode  for  males 
acquiring  HIV infection  is  Heterosexual  (70%).  Past  H/o syphilis  (22%) and other  genital 
ulcers (22%) found in HIV (+) males compared to 8.5% syphilis and 17% other genital ulcer in 
HIV -ve persons. No H/o previous venereal disease more common in HIV -ve males (70%) 
compared to  40% of HIV +ve males (40%).  This  again implies  that  promiscuity  is  higher 
among HIV positive males. Past history of genital discharge (30%) is common among both 
HIV +ve and (-) females. 12 HIV (+) patients (30%) has come for routine check up comparing 
to 60% in HIV (-) group. Among males genital ulcer and in females genital discharge was the 
chief presenting complaints  in both HIV (+)- and (-).  In addition,  HIV positive males and 
females (35%) complained of various constitutional symptoms like fever, weight loss, cough, 
diarrhoea etc. which were conspicuously absent among HIV (-) persons. There symptoms may 
either  due  to  syphilis  (or)  due  to  HIV  infection,  because  secondary  syphilitic  patient  can 
manifest with constitutional symptoms. Early diagnosis by regular screening of risk group will 
greatly help by detecting latent syphilis and HIV, So that early and effective intervention can 
be done.
Vulvovaginal  candidiasis (22%) was the most common associated STD among HIV 
positive  females  compared  to  Trichomoniasis  (30%)  being  most  common  among  HIV 
negatives.  Other  infections  like  Herpes  genitalis  (11%).  Molluscum  contagiosum  (5.5%) 
Bacterial vaginosis (16.5%) found to be more common in HIV positive females.
Among  male  HIV  (+)ves  Herpes  genitalis  (13.5%)  Genital  wart  (18%)  molluscum 
contagiosum (9%), Balanoposthitis (9%) are commonly associated. No associated STD disease 
has been found in HIV negative females (50%) and males (78%).
Non venereal condition associated most commonly in presence of HIV oral candidiasis 
(18%) followed by Dermatophytosis, Herpes zoster, scabies folliculitis, oral hairy leukoplakia, 
Tuberculosis  in  that  order.  This  may be explained in  part,  due  to  decreasing  immunity  of 
patients.
Prevalence  of  early  syphilis  was  high  among  HIV  -ve  patients.  (Primary  (25%), 
secondary (22%) Early latent (35%)) compared to HIV (+) patients.
(Primary  (20%),  secondary  (20%),  Early  latent  (32.5%)).  But  late  latent  syphilitic 
prevalence is high among HIV (+) (25%) compared to HIV -ve (12.5%).
In  this  study  high  VDRL  titre  was  found  in  HIV  positive  group  in  early  syphilis. 
(Primary 1:64 (25%), Secondary 1:64 (62.5%), ELS 1:32 (30%)), Compared to HIV negative 
syphilitics. (Primary 1:16 (20%), Secondary 1:64 (22.5%), ELS 1:16 (15%). 
This result may be due to HIV infection making a decrease in cell mediated immunity, 
and polyclonal B cell activation. Because of decreased Host immune response, patients donot 
manifest primary or secondary stage and directly enters latent stage of disease. Because of 
polyclonal B cell activation there will be hypergammaglobulinemia leading to high average 
VDRL titre in patients with early syphilis in HIV (+). This study has confirmed the findings of 
various studies done abroad42.
CLINICAL PRESENTATION OF SYPHILIS IN HIV
In  this  study,  Early  syphilitic  patients  in  HIV (+)  individuals  are showing increased 
incidence of atypical and aggressive clinical course like multiple chancres in 2 cases, a Giant 
necrotizing ulcer of glans43 involving scrotum and one large extragenital chancre of upper lip. 
Similar findings have been reported in other studies.
Secondary  syphilis  in  presence  of  HIV disease  takes  an  aggressive  course.  Clinical 
presentation of atypical secondary syphilis in HIV positive group are one case of extensive 
pustular syphilid44.
(2) one case of Annular syphilide of face with extensive palmoplantar Keratoderma with 
persistent primary chancre45,46.
(3) One patient with secondary syphilis showing prozone phenomenon.
(4) One  case  with  both  partners  developing  extensive  secondary  syphilitic 
maculopapular  rash  with  female  developing  condyloma  lata  lesion.  Male  with  extensive 
palmoplantar involvement, split papules mucous patches over oral mucosa.
In HIV disease there is depletion of cell mediated immunity,  probably these patients 
with aggressive primary and secondary syphilitic course are due to defect in cell  mediated 
immunity, but unfortunately we were not able to correlate with CD4 counts.
In  the  study,  patients  enter  latent  stage  of  syphilis  more  frequently  than  HIV  (-) 
individuals. One patient with perforation of palate due to Gummatous infiltration was present. 
Off late Gummatous syphilis are not seen now a days but because HIV (+) patients entering 
late latent stage more frequently they are getting into complication like Gumma.
Cardiovascular syphilis (Aortic regurgitation) was found in one patient of HIV (-) males. 
No case in HIV (+) patient with cardiovascular abnormality was found in this study.
In this study, 7(3 HIV (+) and 4 HIV (-)) out of 16 patients in late latent syphilis are 
subjected to Lumbar puncture and CSF Analysis after obtaining consent. One male patient in 
HIV (-) group gave reactive CSF VDRL 1:8, and treated with procaine penicillin 12 lakhs Im 
for  21  days.  But  none  of   HIV  positive  patients  showed  any  CSF  changes  and  hence 
Neurosyphilis was not prevalent in HIV positive patients in this study, in contrast to some of 
the studies done abroad47,48,49.
Response to therapy
All the patients in this study were treated with standard dose of penicillin injections 
either with Benzathine penicillin or procaine penicillin in early and late stages of syphilis. It 
has been recommended from some studies to give 3 injection of Benzathine penicillin in HIV 
positive early syphilitics  instead of single injection, which is the standard dose. But according 
to Gob BT et al.,50,  3 injection had no significant benefit over single injection. So in this study 
only single injection of Benzathine penicillin was given for early syphilitics25,26.
Delayed healing of lesions were observed in 3 out of 8 primary syphilis (37.5%), 2 out 
of 7 secondary syphilitic (28%) with HIV positive persons, similar to study with Yinnon A.M 
et al.,51. But in HIV negative group 1 patient with primary syphilis showed delayed healing.
Though penicillin was found to be an useful drug even in the presence of HIV infection 
delayed serological response was observed in 10 out of 28  (35.8%) patients who come for 
followup. The average time taken for four fold decrease in VDRL titre was 15 weeks in case of 
HIV (+) person compared to  10 weeks in HIV negative syphilitics.
CONCLUSION
This study of male and female syphilitics attending STD clinic clearly points to certain 
changes in the era of HIV / AIDs. In both study groups, males are commonly affected and 90% 
of males and females belongs to sexually active age group (15 - 40 years). 40% of both HIV 
(+) and (-) hailed from rural areas indicating infection increasing in rural population also. 70% 
of males and 90% of females in both study group are married. But in HIV (+) females, high % 
are either widowed (22%) or seperated from husband (17%). 70% of females denies H/o sexual 
act indicating they acquire infection from their partners. Common mode of sexual act in both 
study group was heterosexual (70%). HIV / AIDs still has high incidence in high risk groups 
like Truck drivers (36.5%) mason (18%), Hotel Servant (14%) and other lower socio economic 
groups.  So HIV control  programme has to focus more on these people since they had the 
potentiality  to  spread  the  infection  into General  population.  Factors  like  promiscuity  (both 
PMC  and  EMC)  50%.  Past  H/o  Genital  ulcer  disease  (45%)  in  males  and  non  usage  of 
condoms are important factors responsible for acquisition of syphilis and HIV.
Commonly associated STDs are vulvovaginal - candidiasis (22%), Bacterial vaginosis 
(16.5%), Herpes genitalis (11%) in HIV (+) females compared to Trichomonisis (25%) in HIV 
(-) females. Similarly in HIV (+) males, Genital wart (18%), Herpes Genitalis (13.5%) are the 
common associated STD's.
Non venereal conditions like oral candidiasis (18%) Dermatophytosis (12.5%), Scabies 
(5%), oral hairy leukoplakia (5%) and many constitutional symptoms like fever, weight loss, 
cough, diarrhoea are commonly associated with HIV infection.
In this study Early syphilis was more prevalent in HIV (-) persons (82.5%) than HIV (+) 
(72.5%). But Late latent syphilis seems to be common in HIV (+) 25% than HIV (-) 12.5%. 
Some unusual and atypical courses of syphilis were observed in HIV positive patients. One 
patient (2.5%) with neurosyphilis in HIV negative group has been reported.
High non treponemal (VDRL) titres were seen among HIV positive than among HIV 
negative  syphilitics.  This  was  particularly  evident  in  patients  with  early  syphilis.  Delayed 
serological  response  to  standard  therapy  for  syphilis  were  also  observed  in  HIV  positive 
persons.
Though  penicillin  is  an  useful  drug  even in  the  presence  of  HIV infection  delayed 
healing of lesions occurs in some. Hence, treatment efficacy should be monitored carefully and 
regular follow up to rule out neurosyphilis.
PROFORMA
SL.No. STD No. IP. No.   DATE
Name Age Sex Weight
Address Religion Self / Referred
LITERARCY
Occupational Status : Unemployed / Employed
Monthly Income Rs.
Marital Status : Single - Married - Seperated - Widowed - 
Divorced.
Presenting Complaints
with Duration :
Treatment Taken :
Treated by : STD Specialist - GP's - Others
Sexual History : Heterosexual / Bisexual 
Homosexual : Insertive / Receptive / Both
Age at First
Exposure and with 
H/o. of Recent Exp. : Years, Wife / Known / Unknown / CSW
Marital :
Pre Marital :
Extra Marital :
Previous H/o
Venereal Diseases :
Mode of Sexual Activity : Genital - Anal - Fellatio - Cunnilingus - 
others
Past History of : Blood transfusion - IV drug abuse - tatooing - 
jaundice - Abortion - Herpeslabialis -  Anemia -  TB - Diabetes - 
Prolonged steroid -  prolonged antibiotic  therapy -  drug allergy - 
topical application other
Menstrual H/o :
Obstetrical H/o :
LOCAL EXAMINATION
Genital Examination  :
Speculum Examination :
Per Rectal Examination :
Examination of Anal :
Perianal - perineal region :
GENERAL EXAMINATION
Skin and mucous membrane :
lymphadenopathy Localised / Generalised discrete / matted 
tender / non tender.
Bones and Joints :
CVS and CNS :
INVESTIGATIONS
Microscopy : Grams - Leishman's - Tzanck - Papanicolau - 
wetfilm - KoH.
Dark Field Examination :
Serological : VDRL / TPHA / ELISA / Western blot
Diagnosis :
Treatment :
Follow up :
Conclusions :
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